156
Views
68
CrossRef citations to date
0
Altmetric
Original Article

Review Human Th1 and Th2 Cells: Functional Properties, Regulation of Development and Role in Autoimmunity

, , , &
Pages 301-308 | Published online: 07 Jul 2009

References

  • Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348–2357
  • Mosmann TR, CofFman RL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145–173
  • Salgame P, Abrams JS, Clayberger C, Goldstein H, Convitt J, Modlin RL, Bloom BR. Differing lymphokine profiles and functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279–281
  • Del Prete G, De Carli M, Mastromauro C, Macchia D, Biagiotti R, Ricci M, Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and extretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88: 346–350
  • Mosmann TR, Moore KW. The role of IL-10 in cross-regulation of TH1 and TH2 responses. Immunoparasitol Today 1991; 12: 49–53
  • Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Thl) and type 2 helper (Th2) Tcell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353–360
  • Maggi E, Del Prete G, Macchia D, Parronchi P, Tiri A, Chretien I, Ricci M, Romagnani S. Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol 1988; 18: 1045–1050
  • Del Prete G, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type 1 (Th 1) and Th2 human T cell clones: the help of Thl clones is limited by their cytolytic capacity. J Exp Med 1991; 174: 809–813
  • Fong TAT, Mosmann TR. Alloreactive murine CD8 + T cell clones secrete the TH1 pattern of cytokines. J Immunol 1990; 144: 1744–1752
  • Taguchi T, McGhee JR, Coffman RL, Beagley KW, Eld-Ridge JH, Takatsu K, Kiyono H. Analysis of TH1 and TH2 cells in murine gut-associated tissues. Frequencies of CD4 + and CD8+ T cells that secrete IFN-γ and IL-5. J Immunol 1990; 145: 68–77
  • Paliard X, de Waal Malefyt R, Yssel H, Blanchard D, Chretien I, Abrams J, de Vries JE, Spits H. Simultaneous production of IL-2, IL-4 and IFN-gamma by activated human CD4+ and CD8 + T-cell clones. J Immunol 1988; 141: 849–855, 1988
  • Del Prete G, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445–1449
  • Romagnani S, Maggi E, Del Prete G, Manetti R, Ravina A, Annunziato F, De Carli M, Mazzetti M, Piccinni MP, D'Elios MM, Parronchi P. Role for Thl/Th2 cytokines in HIV infection. Immunol Rev 1994; 140, (in press)
  • Cox FEG, Liew FY. T-cell subsets and cytokines in parasitic infections. Immunol Today 1992; 13: 445–448
  • Rocken M, Urban JF, Shevach EM. Infection breaks T-cell tolerance. Nature 1992; 359: 79–82
  • Evavold BD, Williams SG, Hsu BL, Buus S, Allen PM. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones and T cell hybridomas. J Immunol 1992; 148: 347–353
  • Seder RA, Paul WE, Davis MM, Fazekas de St Groth B. The presence of interleukin 4 during in virtro priming determines the lymphocyte-producing potential of CD4 + T cells from T cell receptor transgenic mice. J Exp med 1992; 176: 1091–1098
  • Hsieh CS, Heimberger AS, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by 11-4 and IL-10 in αβ transgenic system. Proc Natl AcadSci USA 1992; 89: 6065–6069
  • Swain SL., McKenzie DT, Weinberg D, Hancock W. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol 1998; 141: 3445–3455
  • Swain SL. Regulation of the development of distinct subsets of CD4+ T cells. Res Immunol 1991; 142: 14–22
  • Weinberg AD, English ME, Swain SL. Distinct regulation of lymphokine production is found in fresh versus in vitro primed murine helper cells. J Immunol 1990; 144: 1800–1806
  • Romagnani S. Human TH1 and TH2: doubt no more. Immunol Today 1991; 12: 256–257
  • Street NE, Schumacher JH, Fong TAT, Bass H, Fiorentino DF, Leverah JA, Mosmann TR. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of TH1 and TH2 cells. J Immunol 1990; 144: 1629–1639
  • Reiner SL, Wang ZE, Hatan F, Scott P, Locksley RM. Thl and Th2 cell antigen receptors in experimental leishmaniasis. Science 1993; 259: 1457–1460
  • Williams ME, Chang TL, Burke SK, Lichtman AH. Abbas AK. Activation of functionally distinct subsets of CD4 * T lymphocytes. Res Immunol 1991; 142: 23–27
  • Magilavy DB, Fitch FW, Gajewski TF. Murine hepatic accessory cells support the proliferation of Thl but not Th2 helper T lymphocyte clones. J Exp Med 1989; 170: 985–990
  • Schmitz J, Assenmacher M, Radbruch A. Induction of cellular immunity: macrophages are the principal antigen presenting cells for Th cells secreting IFN-γ (Th 1 cells). New Advances on Cytokines, S Romagnani, TR Mosmann, AK Abbas. Raven Press, New York 1992; 131–136
  • Romagnani S. Induction of TH1 and TH2 response: a key role for the 'natural' immune response?. Immunol Today 1992; 13: 379–381
  • Gajewski TF, Joyce J, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J Immunol 1989; 143: 15–22
  • Scott P. Host and parasite factors regulating the development of CD4 + subsets in experimental cutaneous leishmaniasis. Res Immunol 1991; 142: 32–35
  • Coffman RL, Chatelain R, Leal LMCC, Varkila K. Leish-mania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation. Res Immunol 1991; 142: 36–39
  • Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD. Induction of TH1 and TH2 CD4 + subsets during murine Leishmania major infection. Res Immunol 1991; 142: 28–31
  • Parronchi P, De Carli M, Manetti R, Simonelli C, Sam-Pognaro S, Piccinni M-P, Macchia D, Maggi E, Del Prete G, Romagnani S. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th 1 and Th2 human T cell clones. J Immunol, 149: 2977–2983
  • D'Andrea AM, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Wolf SF, Trinchieri G. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387–1398, 1992
  • Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science 1993; 260: 496–497
  • Bendelac A, Schwartz RH. CD4 + and CD8 + T cells acquire specific lymphokine secretion potentials during thymic maturation. Nature 1991; 353: 68–71
  • Ben Sasson SZ, LeGros G, Conrad DH, Finkelman FD, Paul WE. Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete IL-4 and other lymphokines. Proc Natl Acad Sci USA 1990; 87: 1421–1425
  • Del Prete GF, Tiri A, De Carli M, Mariotti S, Pinchera A, Chretien I, Romagnani S, Ricci M. High potential to tumor necrosis factor-α (TNF-α) production of thyroid-infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity. Autoimmunity 1989; 4: 267–272
  • Turner M, Londei M, Feldmann M. Human T cells from autoimmune and normal individuals can produce tumor necrosis factor. Eur J Immunol 1987; 17: 1807–1814
  • Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RFL, Rapoport B, Feldmann M. Autoantigen recognition by thyroid-infiltrating T cells in Graves' disease. Proc Natl Acad Sci USA 1991; 88: 7415–7421
  • De Carli M, D'Elios MM, Mariotti S, Marcocci C, Pinchera A, Ricci M, Romagnani S, Del Prete GF. Cytolytic T cells with Thl-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophtalmopathy. J Clin Endocrinol Metab 1993; 77: 1120–1124
  • Heufelder AE, Bahn RS. Detection and localization of cytokine immuno-reactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23: 10–17
  • Heufelder AE, Smith TJ, Gorman CA, Bahn RS. Increased induction of HLA-DR by interferon-γ in cultured fibroblasts derived from patients with Graves' ophtalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 1991; 73: 307–313
  • Heufelder AE, Wenzel BE, Bahn RS. Cell surface localization of a 72 kilodalton heat shock protein in retroocular fibroblasts from patients with Graves' ophtalmopathy. J Clin Endocrinol Metab 1992; 74: 732–736
  • Haanen J, de Waal Malefijt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spitts H. Selection of a human T helper type 1-like cell subset by Mycobacteria. J Exp Med 1991; 174: 583–592
  • Heufelder AE, Goellner JR, Wenzel BE, Bahn RS. Immuno-histochemical detection and localization of a 72 kilodalton heat shock protein in autoimmune thyroid disease. J Clin Endocrinol Metab 1992; 74: 724–731
  • Foulis AK, McGill M. Farquharson MA. Insulitis in type I (insulin-dependent) diabetes mellitus in man. Macrophages, lymphocytes, and interferon-γ-containing cells. J Pathol 1991; 165: 97–103
  • Brod SA, Benjamin D, Halfer DA. Restricted T cell expression of IL-2/IFN-y mRNA in human inflammatory disease. J Immunol 1991; 147: 810–815
  • Benvenuto R, Paroli M, Buttinelli C, Franco A, Barnaba V, Fieschi C, Balsano F. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with mutliple sclerosis. Clin Exp Immunol 1991; 84: 97–102
  • Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949–954
  • Chofflon M, Juillard C, Juillard P, Gauthier G, Grau GE. Tumor necrosis factor production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine M?IH 1992; 3: 523–531
  • Arend WP, Dayer JP. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305–315
  • Houssiau FA, Devogelaer JP, Van Damme J, Deuxchaines CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784–788
  • Brennan FM, Zachariae COC, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldman M. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990; 20: 2141–2144
  • Di Giovine FS, Nuki G, Duff GW. Tumor necrosis factor in synovial exudates. Ann Rheum Dis 1988; 47: 768–772
  • Firestein GS, Alvaro-Garcia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144: 3347–3353
  • Saxne T, Palladino MA, Heinegard D, Jr, Talal N, WoSheim FA. Detection of tumor necrosis factor α but not tumor necrosis β factor in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041–1045
  • Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre O, Natvig JB. Rheumatoid inflammatory T-cell clones express mostly Thl but also Th2 and mixed (ThO) cytokine patterns. Scand J Immunol 1993; 38: 75–82
  • Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Walde H, Banchereau J. Interleukin-4 inhibits ex vivo production of proinflammatory cytokines and immunoglobulins by rheumatoid synovitis. Arthritis Rheum 1992; 35: 874–883
  • Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?. Clin Exp Immunol 1992; 90: 106–110
  • Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systhemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58–67
  • Grau GE. Implications of cytokines in immunopathology: experimental and clinical data. Eur Cytokine Netw 1990; 1: 203–210
  • Kekow J, Szymkowiak CH, Gross WL. Involvement of cytokines in granuloma formation within primary systemic vasculitis. New Advances on Cytokines, S Romagnani, TR Mosmann, AK Abbas. Raven Press, New York 1992; 341–348
  • Oxholm P, Daniels TE, Bendtzen K. Cytokine expression in labial salivary glands from patients with primary Sjogren's syndrome. Autoimmunity 1992; 12: 185–191
  • Rowe D, Griffith M, Stewart J, Novick D, Beverley PCL, Isenberg DA. HLA class I and class II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjogren's syndrome. Ann Rheum Dis 1987; 46: 580–586
  • Kapsenberg ML, Wierenga EA, Stiekma FEM, Tiggelman AMBC, Bos JD. Thl lymphokine production profiles of nickel-specific CD4+ T lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992; 98: 59–63
  • Benvenuto RA, Bachetoni A, Cinti P, Sallusto F, Franco F, Molajoni ER, Barnaba V, Balsano F, Cortesini R. Enhanced production of interferon-γ by T lymphocytes cloned from rejected kidney grafts. Transplantation 1991; 51: 887–892
  • Dubey C, Bellon B, Druet P. Thl and Th2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals. Eur Cytokine Netw 1991; 2: 147–152
  • Beraud E, Lorberboum-Galski H, Chan CC, Fitzgerald D, Pastan I, Nussenblatt RB. Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cyto-toxin IL-2-PE40. Cell Immunol 1991; 133: 379–389
  • Hahn HJ, Lucke S, Kloting I, Volk HD, Baehr RV, Dia-Mantstein T. Curing BB rats of freshly manifested diabetes by short term treatment with a combination of a monoclonal anti-interleukin-2 receptor antibody and a subthera-peutical dose of cyclosporin A. Eur J Immunol 1987; 18: 2037–2042
  • Kroemer G, Wick G. The role of interleukin 2 in autoimmunity. Immunol Today 1989; 10: 246–251
  • Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically induced autoimmunity. Immunol Today 1991; 12: 223–227

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.